Doctors may have found an easier way to treat prostate cancer — could become new ‘standard of care’ - New York Post
Doctors may have found an easier way to treat prostate cancer — could become new ‘standard of care’ New York Post
Prostate Cancer News
Men seeking help for prostate cancer rises 50pc in a year - The Telegraph
Men seeking help for prostate cancer rises 50pc in a year The Telegraph
Automation cuts prostate cancer drug candidate production from 6 hours to 38 minutes - Medical Xpress
Automation cuts prostate cancer drug candidate production from 6 hours to 38 minutes Medical Xpress
Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer - MedPage Today
Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer MedPage Today
What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape - MedCity News
What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape MedCity News
AUA 2026: Advanced Prostate Cancer - Doublet Versus Triplet: Who Needs Additional Treatment Intensification for mHSPC? - UroToday
AUA 2026: Advanced Prostate Cancer - Doublet Versus Triplet: Who Needs Additional Treatment Intensification for mHSPC? UroToday
AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer - BioSpace
AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer BioSpace
International trial proves AI can design gold-standard cancer treatment plans - news-medical.net
International trial proves AI can design gold-standard cancer treatment plans news-medical.net
Pa. Congressional candidate Alan Bradstock says campaign will continue after cancer diagnosis - WTAE
Pa. Congressional candidate Alan Bradstock says campaign will continue after cancer diagnosis WTAE
Blood test spots failing prostate cancer treatment within 6-12 weeks, study finds - Medical Xpress
Blood test spots failing prostate cancer treatment within 6-12 weeks, study finds Medical Xpress
Dr Polascik on an AI-Driven Urine Volatile Compound Profiling Approach for Prostate Cancer Detection - OncLive
Dr Polascik on an AI-Driven Urine Volatile Compound Profiling Approach for Prostate Cancer Detection OncLive
Prostate Cancer - Focused Ultrasound Foundation
Prostate Cancer Focused Ultrasound Foundation
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study - Nature
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study Nature
PSA screening for prostate cancer reduces disease-specific deaths, new review shows - statnews.com
PSA screening for prostate cancer reduces disease-specific deaths, new review shows statnews.com
Cochrane: Prostate screening combining MRI, blood tests shows promise - AuntMinnie
Cochrane: Prostate screening combining MRI, blood tests shows promise AuntMinnie
Schoolcraft Memorial Hospital brings first advanced prostate cancer therapy to the U.P. - myupnow.com
Schoolcraft Memorial Hospital brings first advanced prostate cancer therapy to the U.P. myupnow.com
Combining standard prostate cancer drugs with a new receptor blocker could provide a powerful, tailored treatment - Earth.com
Combining standard prostate cancer drugs with a new receptor blocker could provide a powerful, tailored treatment Earth.com
University of Michigan health center using AI to plan prostate cancer treatments - MLive.com
University of Michigan health center using AI to plan prostate cancer treatments MLive.com
New marker aids diagnosis for aggressive prostate cancer - UT MD Anderson
New marker aids diagnosis for aggressive prostate cancer UT MD Anderson
David Sher: FASTRACKII Final Results at ESTRO26 in Prostate Cancer - Oncodaily
David Sher: FASTRACKII Final Results at ESTRO26 in Prostate Cancer Oncodaily
Community engagement drives UNC's effort to close prostate cancer care gaps - Urology Times
Community engagement drives UNC's effort to close prostate cancer care gaps Urology Times
Two Brothers, One Lifesaving Roadmap - Sutter Health
Two Brothers, One Lifesaving Roadmap Sutter Health
AUA 2026: Prostate-specific Antigen Endpoints in the Phase 3 PSMAddition Study of [177Lu]Lu-PSMA-617 (177Lu-PSMA-617) combined with ADT and ARPI in Patients with PSMA-positive (PSMA+) Metastatic Hormone-sensitive Prostate Cancer (mHSPC) - UroToday
AUA 2026: Prostate-specific Antigen Endpoints in the Phase 3 PSMAddition Study of [177Lu]Lu-PSMA-617 (177Lu-PSMA-617) combined with ADT and ARPI in Patients with PSMA-positive (PSMA+) Metastatic Hormone-sensitive Prostate Cancer (mHSPC) UroToday
Enzalutamide Plus Leuprolide Yields Prolonged Treatment Suspension in Biochemically Recurrent Prostate Cancer - OncLive
Enzalutamide Plus Leuprolide Yields Prolonged Treatment Suspension in Biochemically Recurrent Prostate Cancer OncLive
BofA raises Candel Therapeutics stock price target on prostate cancer data - Investing.com
BofA raises Candel Therapeutics stock price target on prostate cancer data Investing.com
Novartis reports stronger PSA responses with Pluvicto in earlier-stage prostate cancer - The Pharma Letter
Novartis reports stronger PSA responses with Pluvicto in earlier-stage prostate cancer The Pharma Letter
Fewer radiotherapy sessions for prostate cancer show minimal side effects - news-medical.net
Fewer radiotherapy sessions for prostate cancer show minimal side effects news-medical.net
Prostate cancer patients left navigating ‘knowledge gap’ over treatment options - The Guardian
Prostate cancer patients left navigating ‘knowledge gap’ over treatment options The Guardian
Dr Hafron on a Multidisciplinary Quality Initiative Designed to Mitigate the AEs of ADT in Prostate Cancer - OncLive
Dr Hafron on a Multidisciplinary Quality Initiative Designed to Mitigate the AEs of ADT in Prostate Cancer OncLive
Dr Garzotto on Aglatimagene Besadenovec Plus Valacyclovir and EBRT in Localized Prostate Cancer - OncLive
Dr Garzotto on Aglatimagene Besadenovec Plus Valacyclovir and EBRT in Localized Prostate Cancer OncLive
A need for better understanding of prostate cancer reirradiation - The Guardian
A need for better understanding of prostate cancer reirradiation The Guardian
Testosterone Therapy Ups Sexual Desire, Activity After Low Grade Prostate Cancer Surgery - Renal and Urology News
Testosterone Therapy Ups Sexual Desire, Activity After Low Grade Prostate Cancer Surgery Renal and Urology News
Emory’s Winship Prostate Cancer Screening Bus - Free Screening - Cobb County (.gov)
Emory’s Winship Prostate Cancer Screening Bus - Free Screening Cobb County (.gov)
Experimental drug shows promise for some patients with advanced prostate cancer - Medical Xpress
Experimental drug shows promise for some patients with advanced prostate cancer Medical Xpress
Banu Atalar: Pelvic RT Did Not Improve Outcomes in High-Risk Prostate Cancer - Oncodaily
Banu Atalar: Pelvic RT Did Not Improve Outcomes in High-Risk Prostate Cancer Oncodaily
Follow-Up After Focal Cryo-Ablation in Intermediate Favorable Risk Prostate Cancer - OncLive
Follow-Up After Focal Cryo-Ablation in Intermediate Favorable Risk Prostate Cancer OncLive
Enzalutamide Plus Radium-223 Demonstrates Delayed but Substantial Long-Term Survival Benefit in mCRPC - OncLive
Enzalutamide Plus Radium-223 Demonstrates Delayed but Substantial Long-Term Survival Benefit in mCRPC OncLive
Hometown Health: Simple blood test could prevent death from prostate cancer - WDBJ7
Hometown Health: Simple blood test could prevent death from prostate cancer WDBJ7
Mark Fuhrman, LAPD detective at center of controversy in OJ Simpson's murder trial, dies at age 74 - ABC7 Los Angeles
Mark Fuhrman, LAPD detective at center of controversy in OJ Simpson's murder trial, dies at age 74 ABC7 Los Angeles
Hometown Health: A Simple Blood Test Could Prevent Death from Prostate Cancer - WDBJ7
Hometown Health: A Simple Blood Test Could Prevent Death from Prostate Cancer WDBJ7